IPO Year: 2021
Exchange: NASDAQ
Estrella Immunopharma, Inc. (NASDAQ:ESLA, ESLAW))) ("Estrella", "Estrella Immunopharma", or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancers and autoimmune diseases, today announced the appointment of Hong Zhang as Chairperson and a member of its Board of Directors. This appointment comes shortly after the Company dosed the first patient in its Phase I/II clinical trial (STARLIGHT-1) for EB103, an autologous T-cell therapy for adult patients with relapsed or refractory (R/R) B-cell Non-Hodgkin's Lymphoma (NHL). Ms. Zhang's appointment increases the size of Estrella's Board from five to six dire
3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)
10-Q - Estrella Immunopharma, Inc. (0001844417) (Filer)
8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)
8-K/A - Estrella Immunopharma, Inc. (0001844417) (Filer)
10-K/A - Estrella Immunopharma, Inc. (0001844417) (Filer)
424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)
10-K - Estrella Immunopharma, Inc. (0001844417) (Filer)
424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)
8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)
424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)
Estrella Immunopharma, Inc. (NASDAQ:ESLA, ESLAW))) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced that the first patient enrolled in its STARLIGHT-1 Phase I/II clinical trial has achieved a complete response (CR) one month after receiving an infusion of EB103 CD19- Redirected ARTEMIS® T Cells. In a clinical trial, a complete response means that no detectable signs of disease or cancer remain after treatment. The patient, diagnosed with follicular lymphoma grade 3A with high-risk 3B symptoms, was enrolled in the STARLIGHT-1 trial at UC Davis Compreh
Estrella Immunopharma, Inc. (NASDAQ:ESLA, ESLAW))) ("Estrella", "Estrella Immunopharma", or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancers and autoimmune diseases, today announced the appointment of Hong Zhang as Chairperson and a member of its Board of Directors. This appointment comes shortly after the Company dosed the first patient in its Phase I/II clinical trial (STARLIGHT-1) for EB103, an autologous T-cell therapy for adult patients with relapsed or refractory (R/R) B-cell Non-Hodgkin's Lymphoma (NHL). Ms. Zhang's appointment increases the size of Estrella's Board from five to six dire
Gainers Apollomics (NASDAQ:APLM) stock rose 10.9% to $0.61 during Tuesday's after-market session. The market value of their outstanding shares is at $54.5 million. Cara Therapeutics (NASDAQ:CARA) shares moved upwards by 7.36% to $0.78. The company's market cap stands at $42.8 million. Coeptis Therapeutics (NASDAQ:COEP) shares moved upwards by 6.66% to $0.32. The company's market cap stands at $10.9 million. Titan Pharma (NASDAQ:TTNP) shares rose 6.44% to $7.75. The market value of their outstanding shares is at $5.8 million. BioSig Technologies (NASDAQ:BSGM) shares increased by 6.38% to $0.5. The market value of their outstanding shares is at $4.6 million. Iridex (NASDAQ:IRIX) stock in
Gainers Talphera (NASDAQ:TLPH) shares moved upwards by 15.6% to $1.3 during Friday's after-market session. The company's market cap stands at $22.0 million. As per the news, the Q4 earnings report came out 2 days ago. Genelux (NASDAQ:GNLX) shares increased by 10.06% to $7.0. The market value of their outstanding shares is at $187.0 million. Estrella Immunopharma (NASDAQ:ESLA) stock rose 8.65% to $1.13. The market value of their outstanding shares is at $41.3 million. Inspire Veterinary (NASDAQ:IVP) stock increased by 8.5% to $0.06. The market value of their outstanding shares is at $1.6 million. NRX Pharmaceuticals (NASDAQ:NRXP) shares moved upwards by 5.15% to $0.65. The market value o
Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 26.1% to $3.33 during Wednesday's regular session. The company's market cap stands at $20.2 million. MAIA Biotechnology (AMEX:MAIA) shares rose 26.02% to $1.55. The company's market cap stands at $26.2 million. Kintara Therapeutics (NASDAQ:KTRA) stock moved upwards by 24.42% to $0.16. Anitra (AMEX:AZTR) shares moved upwards by 22.64% to $1.95. The market value of their outstanding shares is at $23.5 million. Evolus (NASDAQ:EOLS) shares rose 17.74% to $12.28. The market value of their outstanding shares is at $709.3 million. Jasper Therapeutics (NASDAQ:JSPR) stock increased by 16.42% to $10.42. The market value of their outstand
Shares of DatChat, Inc. (NASDAQ:DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers RiskOn International, Inc. (NASDAQ:ROI) shares rose 51.3% to $0.2250 in pre-market trading. Meta Materials Inc. (NASDAQ:MMAT) shares jumped 33.2% to $0.0966 in pre-market trading after surging over 20% on Tuesday. LQR House Inc. (NASDAQ:LQR) gained 25.2% to $2.53 in pre-market trading after dipping 45% on Tuesday. LQR House announced an increase of its share buyback program to $5 million. Kintara Therapeutics, Inc.
Gainers Moleculin Biotech (NASDAQ:MBRX) shares moved upwards by 8.7% to $0.72 during Tuesday's after-market session. The market value of their outstanding shares is at $23.9 million. Evoke Pharma (NASDAQ:EVOK) stock increased by 7.27% to $0.92. The company's market cap stands at $3.0 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 7.2% to $2.38. The market value of their outstanding shares is at $1.6 million. CNS Pharma (NASDAQ:CNSP) stock increased by 6.45% to $0.76. The market value of their outstanding shares is at $4.7 million. Atreca (NASDAQ:BCEL) stock increased by 6.29% to $0.27. The company's market cap stands at $10.6 million. ASLAN Pharma (NASDAQ:ASLN) stock increas
Gainers Aclarion (NASDAQ:ACON) stock rose 21.6% to $3.82 during Friday's after-market session. The company's market cap stands at $3.2 million. Outset Medical (NASDAQ:OM) shares rose 10.61% to $4.95. The market value of their outstanding shares is at $248.5 million. Absci (NASDAQ:ABSI) stock moved upwards by 9.77% to $4.38. The market value of their outstanding shares is at $407.0 million. Processa Pharma (NASDAQ:PCSA) shares rose 8.71% to $0.29. The company's market cap stands at $7.0 million. Cara Therapeutics (NASDAQ:CARA) stock increased by 7.94% to $0.62. The company's market cap stands at $33.5 million. Monopar Therapeutics (NASDAQ:MNPR) shares moved upwards by 6.44% to $0.46. Th
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 37.0% to $0.15 during Friday's pre-market session. The company's market cap stands at $7.5 million. Jin Medical International (NASDAQ:ZJYL) shares rose 19.23% to $93.0. The market value of their outstanding shares is at $720.7 million. Aileron Therapeutics (NASDAQ:ALRN) stock increased by 18.13% to $4.3. The market value of their outstanding shares is at $21.0 million. Aditxt (NASDAQ:ADTX) shares rose 15.18% to $6.22. The company's market cap stands at $3.0 million. Akso Health Group (NASDAQ:AHG) stock moved upwards by 14.59% to $1.02. The company's market cap stands at $23.3 million. DarioHealth (NASDAQ:DRIO) shares moved upw
Gainers Exicure (NASDAQ:XCUR) stock increased by 29.8% to $0.8 during Wednesday's pre-market session. The company's market cap stands at $6.9 million. Telesis Bio (NASDAQ:TBIO) shares moved upwards by 21.88% to $0.46. The market value of their outstanding shares is at $13.6 million. Jin Medical International (NASDAQ:ZJYL) shares moved upwards by 21.33% to $110.0. The company's market cap stands at $852.5 million. Estrella Immunopharma (NASDAQ:ESLA) stock increased by 15.78% to $1.1. The company's market cap stands at $38.7 million. Amarin Corp (NASDAQ:AMRN) shares increased by 15.35% to $1.12. The market value of their outstanding shares is at $457.2 million. Bio-Path Hldgs (NASDAQ:BPT
Gainers Longboard Pharmaceuticals (NASDAQ:LBPH) shares increased by 157.0% to $15.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $369.7 million. Cue Health (NASDAQ:HLTH) stock moved upwards by 40.61% to $0.23. The market value of their outstanding shares is at $35.3 million. Voyager Therapeutics (NASDAQ:VYGR) stock rose 27.72% to $10.78. The market value of their outstanding shares is at $474.2 million. NGM Biopharmaceuticals (NASDAQ:NGM) stock rose 26.89% to $1.09. The company's market cap stands at $90.1 million. Estrella Immunopharma (NASDAQ:ESLA) stock rose 15.31% to $1.28. The market value of their outstanding shares is at $45.0 million.
Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 378.8% to $31.65 during Monday's pre-market session. The company's market cap stands at $1.1 billion. Alterity Therapeutics (NASDAQ:ATHE) stock increased by 196.98% to $4.93. The company's market cap stands at $20.0 million. Lucy Scientific Discovery (NASDAQ:LSDI) stock rose 95.33% to $0.41. The company's market cap stands at $7.2 million. Genetic Technologies (NASDAQ:GENE) shares rose 24.08% to $0.85. The company's market cap stands at $16.3 million. Mira Pharmaceuticals (NASDAQ:MIRA) shares moved upwards by 22.36% to $4.65. The market value of their outstanding shares is at $68.7 million. Estrella Immunopharma (NASDAQ: